Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2023-07-03 00:00:00 ET · period of report 2023-06-29 · accession 0001415889-23-010561 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-07-03 | 2023-06-29 | KNSA | Popovits Kimberly J | Dir | M - OptEx | — | +5,000 | 5,000 | New | — |
| D | 2023-07-03 | 2023-06-29 | KNSA | Popovits Kimberly J | Dir | M - OptEx | $0.00 | -5,000 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Share | 2023-06-29 | M | A | 5,000 | — | 5,000 | D | — | — | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. |
| 2 | Derivative | Restricted Share Units | 2023-06-29 | M | D | 5,000 | $0.00 | 0 | D | — · — to — | 5,000 Class A Common Shares | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. (F2) The RSUs vested in a single installment on June 29, 2023; there was no expiration date for the RSUs. |